Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries

Background Guidelines recommend that coronary slow flow phenomenon (CSFP), defined as corrected thrombolysis in myocardial infarction frame count (CTFC) >$$ > $$27, can diagnose coronary microvascular dysfunction (CMD) in patients with angina and nonobstructed coronary arteries. CSFP has also...

Full description

Bibliographic Details
Main Authors: Utkarsh Dutta, Aish Sinha, Ozan M. Demir, Howard Ellis, Haseeb Rahman, Divaka Perera
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.027664
_version_ 1797905036353732608
author Utkarsh Dutta
Aish Sinha
Ozan M. Demir
Howard Ellis
Haseeb Rahman
Divaka Perera
author_facet Utkarsh Dutta
Aish Sinha
Ozan M. Demir
Howard Ellis
Haseeb Rahman
Divaka Perera
author_sort Utkarsh Dutta
collection DOAJ
description Background Guidelines recommend that coronary slow flow phenomenon (CSFP), defined as corrected thrombolysis in myocardial infarction frame count (CTFC) >$$ > $$27, can diagnose coronary microvascular dysfunction (CMD) in patients with angina and nonobstructed coronary arteries. CSFP has also historically been regarded as a sign of coronary endothelial dysfunction (CED). We sought to validate the utility of CTFC, as a binary classifier of CSFP and as a continuous variable, to diagnose CMD and CED. Methods and Results Patients with angina and nonobstructed coronary arteries had simultaneous coronary pressure and flow velocity measured using a dual sensor‐tipped guidewire during rest, adenosine‐mediated hyperemia, and intracoronary acetylcholine infusion. CMD was defined as the inability to augment coronary blood flow in response to adenosine (coronary flow reserve <2.5) and CED in response to acetylcholine (acetylcholine flow reserve ≤1.5); 152 patients underwent assessment using adenosine, of whom 82 underwent further acetylcholine testing. Forty‐six patients (30%) had CSFP, associated with lower flow velocity and higher microvascular resistance as compared with controls (16.5±$$ \pm $$6.9 versus 20.2±$$ \pm $$6.9 cm/s; P=0.001 and 6.26±$$ \pm $$1.83 versus 5.36±$$ \pm $$1.83 mm Hg/cm/s; P=0.009, respectively). However, as a diagnostic test, CSFP had poor sensitivity and specificity for both CMD (26.7% and 65.2%) and CED (21.1% and 56.0%). Furthermore, on receiver operating characteristics analyses, CTFC could not predict CMD or CED (area under the curve, 0.41 [95% CI, 0.32%–0.50%] and 0.36 [95% CI, 0.23%–0.49%], respectively). Conclusions In patients with angina and nonobstructed coronary arteries, CSFP and CTFC are not diagnostic of CMD or CED. Guidelines supporting the use of CTFC in the diagnosis of CMD should be revisited.
first_indexed 2024-04-10T09:58:41Z
format Article
id doaj.art-3c499fe0cd814f28ab08de1af5c94dcb
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-10T09:58:41Z
publishDate 2023-01-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-3c499fe0cd814f28ab08de1af5c94dcb2023-02-16T10:55:33ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802023-01-0112110.1161/JAHA.122.027664Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary ArteriesUtkarsh Dutta0Aish Sinha1Ozan M. Demir2Howard Ellis3Haseeb Rahman4Divaka Perera5School of Cardiovascular Medicine and Sciences British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre, King’s College London London UKSchool of Cardiovascular Medicine and Sciences British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre, King’s College London London UKSchool of Cardiovascular Medicine and Sciences British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre, King’s College London London UKSchool of Cardiovascular Medicine and Sciences British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre, King’s College London London UKSchool of Cardiovascular Medicine and Sciences British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre, King’s College London London UKSchool of Cardiovascular Medicine and Sciences British Heart Foundation Centre of Excellence and National Institute for Health Research Biomedical Research Centre, King’s College London London UKBackground Guidelines recommend that coronary slow flow phenomenon (CSFP), defined as corrected thrombolysis in myocardial infarction frame count (CTFC) >$$ > $$27, can diagnose coronary microvascular dysfunction (CMD) in patients with angina and nonobstructed coronary arteries. CSFP has also historically been regarded as a sign of coronary endothelial dysfunction (CED). We sought to validate the utility of CTFC, as a binary classifier of CSFP and as a continuous variable, to diagnose CMD and CED. Methods and Results Patients with angina and nonobstructed coronary arteries had simultaneous coronary pressure and flow velocity measured using a dual sensor‐tipped guidewire during rest, adenosine‐mediated hyperemia, and intracoronary acetylcholine infusion. CMD was defined as the inability to augment coronary blood flow in response to adenosine (coronary flow reserve <2.5) and CED in response to acetylcholine (acetylcholine flow reserve ≤1.5); 152 patients underwent assessment using adenosine, of whom 82 underwent further acetylcholine testing. Forty‐six patients (30%) had CSFP, associated with lower flow velocity and higher microvascular resistance as compared with controls (16.5±$$ \pm $$6.9 versus 20.2±$$ \pm $$6.9 cm/s; P=0.001 and 6.26±$$ \pm $$1.83 versus 5.36±$$ \pm $$1.83 mm Hg/cm/s; P=0.009, respectively). However, as a diagnostic test, CSFP had poor sensitivity and specificity for both CMD (26.7% and 65.2%) and CED (21.1% and 56.0%). Furthermore, on receiver operating characteristics analyses, CTFC could not predict CMD or CED (area under the curve, 0.41 [95% CI, 0.32%–0.50%] and 0.36 [95% CI, 0.23%–0.49%], respectively). Conclusions In patients with angina and nonobstructed coronary arteries, CSFP and CTFC are not diagnostic of CMD or CED. Guidelines supporting the use of CTFC in the diagnosis of CMD should be revisited.https://www.ahajournals.org/doi/10.1161/JAHA.122.027664anginaendothelial dysfunctionmicrovascular dysfunctionTIMI frame count
spellingShingle Utkarsh Dutta
Aish Sinha
Ozan M. Demir
Howard Ellis
Haseeb Rahman
Divaka Perera
Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
angina
endothelial dysfunction
microvascular dysfunction
TIMI frame count
title Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries
title_full Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries
title_fullStr Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries
title_full_unstemmed Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries
title_short Coronary Slow Flow Is Not Diagnostic of Microvascular Dysfunction in Patients With Angina and Unobstructed Coronary Arteries
title_sort coronary slow flow is not diagnostic of microvascular dysfunction in patients with angina and unobstructed coronary arteries
topic angina
endothelial dysfunction
microvascular dysfunction
TIMI frame count
url https://www.ahajournals.org/doi/10.1161/JAHA.122.027664
work_keys_str_mv AT utkarshdutta coronaryslowflowisnotdiagnosticofmicrovasculardysfunctioninpatientswithanginaandunobstructedcoronaryarteries
AT aishsinha coronaryslowflowisnotdiagnosticofmicrovasculardysfunctioninpatientswithanginaandunobstructedcoronaryarteries
AT ozanmdemir coronaryslowflowisnotdiagnosticofmicrovasculardysfunctioninpatientswithanginaandunobstructedcoronaryarteries
AT howardellis coronaryslowflowisnotdiagnosticofmicrovasculardysfunctioninpatientswithanginaandunobstructedcoronaryarteries
AT haseebrahman coronaryslowflowisnotdiagnosticofmicrovasculardysfunctioninpatientswithanginaandunobstructedcoronaryarteries
AT divakaperera coronaryslowflowisnotdiagnosticofmicrovasculardysfunctioninpatientswithanginaandunobstructedcoronaryarteries